Antitumor activity of the protein kinase inhibitor 1-(β-D-2′-deoxyribofuranosyl)-4,5,6,7-tetrabromo- 1H-benzimidazole in breast cancer cell lines
Mirosława Koronkiewicz(Narodowy Instytut Leków), Andrzej Orzeszko(Warsaw University of Life Sciences)
Cited by 8